Lipid management and haemorrhagic stroke

Rakhi talks to Catherine and Kavan about optimising lipid management in patients who have had a haemorrhagic stroke. They discuss the importance of confirming diagnosis, risks of statin use in haemorrhagic stroke, how to use QRISK scores in this patient group, and when to seek specialist advice. This is a follow up podcast to our 'Primary care discussions: Lipid management' webinar. You can find the webinar recording here: https://www.sps.nhs.uk/articles/primary-care-discussions-lipid-management/ Speakers: Catherine Tucker, Senior Clinical Pharmacist Lipid Clinic and Integrated Care Team, Northumbria Healthcare NHS Foundation Trust and CVD Medicines Optimisation Pharmacist, CVD Prevention Network, North East and North Cumbria Integrated Care Board Kavan Nagi, Lead Cardiovascular Pharmacist, Buckinghamshire Healthcare Trust and Lead ICS Lipid Specialist Pharmacist, NHS Frimley Integrated Care Board Rakhi Aggarwal, Primary Care Lead, Medicines Use and Safety, NHS Specialist Pharmacy Service Resources discussed by the speakers: NHSE Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2020/04/lipid-management-pathway-v7.pdf Stroke Association https://www.stroke.org.uk/ QRISK https://www.qrisk.org/ SPARCL trial The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559 https://www.nejm.org/doi/full/10.1056/NEJMoa061894